Trial Profile
Genistein Use in Postmenopausal Women With Metabolic Syndrome
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Genistein (Primary)
- Indications Metabolic syndrome
- Focus Therapeutic Use
- 17 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jul 2011 New trial record